Circulating Tumor Cells Detectors Market

A circulating tumor cell (CTC) is a cell that has shed into the vasculature or lymphatics from a primary tumor and is carried around the body in the blood circulation.
Circulating Tumor Cells Detectors Market contains market size and forecasts of Circulating Tumor Cells (CTCs) Detectors in global, including the following market information:
Global Circulating Tumor Cells (CTCs) Detectors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Circulating Tumor Cells (CTCs) Detectors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Circulating Tumor Cells (CTCs) Detectors companies in 2021 (%)
The global Circulating Tumor Cells (CTCs) Detectors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Circulating Tumor Cells (CTCs) Detectors include Johnson & Johnson, Epic Sciences, CytoTrack, Qiagen, BioCept, ApoCell, Biofluidica and Clearbridge Biomedics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Circulating Tumor Cells (CTCs) Detectors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circulating Tumor Cells (CTCs) Detectors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Circulating Tumor Cells (CTCs) Detectors Market Segment Percentages, by Type, 2021 (%)
Blood Diagnosis
Cytologic Diagnosis
Genetic Diagnosis
Other
Global Circulating Tumor Cells (CTCs) Detectors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Circulating Tumor Cells (CTCs) Detectors Market Segment Percentages, by Application, 2021 (%)
Medical Center
Hospital
Medical Research
Other
Global Circulating Tumor Cells (CTCs) Detectors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Circulating Tumor Cells (CTCs) Detectors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Circulating Tumor Cells (CTCs) Detectors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Circulating Tumor Cells (CTCs) Detectors revenues share in global market, 2021 (%)
Key companies Circulating Tumor Cells (CTCs) Detectors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Circulating Tumor Cells (CTCs) Detectors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Epic Sciences
CytoTrack
Qiagen
BioCept
ApoCell
Biofluidica
Clearbridge Biomedics